Compare PPSI & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPSI | LSTA |
|---|---|---|
| Founded | 2008 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1M | 28.9M |
| IPO Year | 2008 | 2000 |
| Metric | PPSI | LSTA |
|---|---|---|
| Price | $2.96 | $1.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 56.9K | ★ 121.3K |
| Earning Date | 04-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | ★ N/A | N/A |
| Revenue | $27,627,000.00 | ★ $35,283,868.00 |
| Revenue This Year | $2.71 | N/A |
| Revenue Next Year | $22.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 20.75 | ★ 56.90 |
| 52 Week Low | $2.35 | $0.99 |
| 52 Week High | $6.29 | $5.07 |
| Indicator | PPSI | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | 38.46 | 26.19 |
| Support Level | $2.75 | $0.99 |
| Resistance Level | $3.36 | $2.19 |
| Average True Range (ATR) | 0.23 | 0.13 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 26.00 | 33.68 |
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets. The Company launched two new product platforms namely, PRYMUS, a new, mobile on-site power system concentrating on customers with requirements of 1-10 megawatts of mobile power and PowerCore, a residential and small commercial based primary generator system integrating a DC fast charger into one solution.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.